WCG has released its WCG Clinical Research Trends & Insights 2024 report just as the new year unfolds, focusing on key topics including artificial intelligence (AI), site readiness, decentralized trials (DCT), patient recruitment hurdles in cancer trials and more.

The report, which explores industry trends, changes and innovations and areas pivotal to the future of clinical research, is informed by the thought leadership of 12 WCG experts across four sections (DE&I, decentralized and hybrid trials, site readiness and emerging opportunities).

Key topics covered in the report include:

• AI
• Site readiness
• Patient recruitment
• DE&I
• Oncology
• Rare diseases
• Psychedelics
• Digital biomarkers
• Decentralized and hybrid trials

“In our post-pandemic world, we are seeing the traditional approach to clinical trials being challenged, with sponsors, CROs, and sites using the flexibility and innovation driven by the pandemic response to address unmet needs in other disease areas,” Sam Srivastava, CEO of WCG, said.

“There is continued focus on protecting the rights and safety of participants and prioritizing diversity in the clinical trials space,” he continued. “It will be through novel uses of data, technology, and integrated workflows that will allow us to reimagine how we accelerate clinical research. These influential changes demand a deeper understanding and examination of the impact they will undoubtedly have on the clinical research industry.”

Access the report here.